Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormone mimicry.

Literature DB >> 8677438

Hormone mimicry.

J A Wells¹.

Abstract

Mesh：

Substances：

Year: 1996 PMID： 8677438 DOI： 10.1126/science.273.5274.449

Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

Review 1. Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors: Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal: Sports Med Date: 2003 Impact factor: 11.136

Review 2. Drugs for increasing oxygen and their potential use in doping: a review.

Authors: Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal: Sports Med Date: 2003 Impact factor: 11.136

3. Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction.

Authors: Rob Meloen; Peter Timmerman; Hans Langedijk
Journal: Mol Divers Date: 2004 Impact factor: 2.943

Review 4. Novel approaches in anti-arenaviral drug development.

Authors: Andrew M Lee; Antonella Pasquato; Stefan Kunz
Journal: Virology Date: 2010-12-22 Impact factor: 3.616

5. FcαRI binding at the IgA1 C_H2-C_H3 interface induces long-range conformational changes that are transmitted to the hinge region.

Authors: Monica T Posgai; Sam Tonddast-Navaei; Manori Jayasinghe; George M Ibrahim; George Stan; Andrew B Herr
Journal: Proc Natl Acad Sci U S A Date: 2018-09-04 Impact factor: 11.205

Hormone mimicry.

Review 1. Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Review 2. Drugs for increasing oxygen and their potential use in doping: a review.

3. Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction.

Review 4. Novel approaches in anti-arenaviral drug development.

5. FcαRI binding at the IgA1 C_H2-C_H3 interface induces long-range conformational changes that are transmitted to the hinge region.

Review 6. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.

7. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.

8. A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.

9. Erythropoietin use and abuse.

Hormone mimicry.

Review 1. Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Review 2. Drugs for increasing oxygen and their potential use in doping: a review.

3. Bioactive peptides based on diversity libraries, supramolecular chemistry and rational design: a new class of peptide drugs. Introduction.

Review 4. Novel approaches in anti-arenaviral drug development.

5. FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.

Review 6. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.

7. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.

8. A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.

9. Erythropoietin use and abuse.

5. FcαRI binding at the IgA1 C_H2-C_H3 interface induces long-range conformational changes that are transmitted to the hinge region.